IFC Advisory appointed Financial PR adviser to Nuformix plc, the pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing
Client Appointment
IFC Advisory appointed by Nuformix plc
31
Jan
Jan
IFC Advisory appointed Financial PR adviser to Nuformix plc, the pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing
IFC Advisory advises on the Euro 128m sale of LSE listed Yew Grove REIT plc
IFC Advisory advises on the Euro 128m sale of LSE listed Yew Grove REIT plc, [...]
Feb
IFC Advisory advises on the sale of AIM listed Universe Group plc
IFC Advisory advises on the sale of AIM listed Universe Group plc, a leading developer [...]
Jan
Vector Capital appoint IFC Advisory
IFC Advisory appointed Financial PR adviser to AIM listed Vector Capital, the commercial lending group [...]
Jan